Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea Therapeutics. Akcea is a development and commercialization company focused on helping patients with serious diseases. The company is based in Boston, MA. Here are some of the most interesting excerpts from our discussion:
You’re a neurologist
We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics, a biotech focused on the discovery and development of precision medicines for cancer. The company is based in Cambridge, MA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common challenges you meet with during the
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
Check back regularly for more.
We recently talked with Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, a CRO based in the Research Triangle Park area of North Carolina. We wanted to share these excerpts
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they are changing, and how they are likely to change. We wanted to share this excerpt from the conversation:
What are your predictions for how clinical operations will work— or should work—in the future?
Over the last year, we’ve been utilizing data analytics more and